Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. [electronic resource]
Producer: 20160714Description: 2655-64 p. digitalISSN:- 1600-6143
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antilymphocyte Serum -- therapeutic use
- Basiliximab
- Cytomegalovirus Infections -- epidemiology
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Everolimus -- administration & dosage
- Female
- Graft Rejection -- prevention & control
- Humans
- Immunosuppressive Agents -- administration & dosage
- Incidence
- Kidney Transplantation
- Male
- Middle Aged
- Mycophenolic Acid -- therapeutic use
- Postoperative Complications -- epidemiology
- Prednisone -- therapeutic use
- Prospective Studies
- Recombinant Fusion Proteins -- therapeutic use
- Sirolimus -- therapeutic use
- Tacrolimus -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.